Pulwama, June 25 (Scoop News)-Chief Minister, Mufti Mohammad Sayeed, today constituted district-level Nodal Committees to monitor sector-wise progress of vital schemes integrated into the newly-introduced Capital Expenditure Plans. He said with developmental spending hiked this year, there is an urgent need to build capacities to spend the funds. “The issue is not of availability of […]
Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) under Investigation over potential Wrongdoing
The Shareholders Foundation announces that an investigation for long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) shares is ongoing concerning potential breaches of fiduciary duties by certain Galectin Therapeutics officers and directors. Shares of Galectin Therapeutics Inc. (NASDAQ:GALT) declined from $15.32 per share on July 25, 2014, to as low as $5.06 per share […]
Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) under Investigation over potential Securities Laws Violations
The Shareholders Foundation announces that an investigation on behalf of investors of Galectin Therapeutics Inc. (NASDAQ:GALT) shares was launched over potential securities laws violations by Galectin Therapeutics Inc. and certain of its directors and officers. Investors who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT) and currently hold any of those NASDAQ:GALT shares have certain options […]
Investor Alert: Investigation concerning potential Wrongdoing at Galectin Therapeutics Inc. (NASDAQ:GALT)
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) shares is ongoing concerning potential breaches of fiduciary duties by certain Galectin Therapeutics officers and directors. Investors who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT) and currently hold any of those NASDAQ:GALT shares have certain […]
Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) faces Investigation of potential Wrongdoing
The Shareholders Foundation announces that an investigation on behalf of current long-term investors in shares of Galectin Therapeutics Inc. (NASDAQ:GALT) was launched concerning potential breaches of fiduciary duties by certain directors and officers. Investors who are current long term investors in Galectin Therapeutics Inc. (NASDAQ:GALT) shares, have certain options and should contact the Shareholders Foundation […]
Investor Alert: Deadline in Lawsuit against Galectin Therapeutics Inc. (NASDAQ:GALT) on September 29, 2014
The Shareholders Foundation announces that a deadline is coming up on September 29, 2014 in the lawsuit filed for investors of Galectin Therapeutics Inc. (NASDAQ:GALT) over alleged Violations of Federal Securities Laws by Galectin Therapeutics. Investors who purchased shares of Galectin Therapeutics Inc. (NASDAQ:GALT) have certain options and there are strict and short deadlines running. […]